Pomegranate Extract
Supplements · Antioxidants · Supplement, Typed Supps
A concentrated extract from a fruit with a genuinely consistent human research signal for modestly lowering blood pressure — though its more exciting anti-aging claims depend on gut bacteria that not everyone has in the same amount.
Stage by stage
- Intake (Capsule or juice): Taken with food.
- Stomach and small intestine (Mostly unabsorbed): Most active compounds pass through largely unabsorbed.
- Colon (Bacterial conversion): Gut bacteria convert ellagitannins into urolithins, with big variation between individuals.
- Bloodstream (Circulates): Absorbed urolithins circulate and are linked to antioxidant and blood-pressure effects.
What the evidence supports
- Modestly lowering blood pressure with regular use — moderate evidence. A meta-analysis of randomized trials found pomegranate juice and extract reduced systolic blood pressure by roughly 5 mmHg and diastolic by roughly 2 mmHg on average — a real, consistent, but modest effect, typically emerging after several weeks.
- Reducing markers of oxidative stress — moderate evidence. Several human RCTs report consistent reductions in oxidative stress biomarkers with pomegranate extract, which is a more consistent human signal than many other antioxidant supplements manage.
- Producing meaningful anti-aging or mitochondrial benefits via urolithin A generated from typical supplemental intake — insufficient evidence. Urolithin A production depends heavily on an individual’s gut microbiome — so-called “producer” versus “non-producer” phenotypes — meaning the same pomegranate extract dose may generate very different urolithin exposure between people, and the clinical outcome data for urolithin A itself (as opposed to whole pomegranate extract) comes from separate, more recent trials using the purified compound directly.
- Evidence on General oral tolerability at studied doses — moderate evidence. Pomegranate extract has been well tolerated in the RCTs conducted so far, with occasional mild GI upset reported.
Typical dose
Trials commonly use extract standardized to punicalagin content, often around 800 mg/day of extract or equivalent juice amounts
Upper limit: No established UL
Timing
Take with food; consistent daily use for several weeks is how it’s been studied.
Time to effect
- Weeks: Blood pressure effects have generally shown up after about 4–8 weeks of consistent use in trials.
Common myth
“Pomegranate extract’s antioxidant benefits work the same for everyone.” In reality: Much of its activity depends on gut bacteria converting its ellagitannins into urolithins, and how much urolithin A a person produces varies enormously based on their individual gut microbiome — so the same dose can act quite differently from person to person.
More in Antioxidants
In the glossary
Sources